Skip to main content

Table 1 Characteristics of the studies included in the meta-analysis

From: Mobile health in the management of type 1 diabetes: a systematic review and meta-analysis

Author Year, Country

Study types

Number of participants (I/C)

Age years (I/C)

Sex(M/F)

Diabetes duration (I/C)

Intervention type

HbA1c at baseline (I/C)

HbA1c at follow-up (I/C)

Follow-up (months)

I

C

Han, Y 2015, USA

RCT

20 (10/10)

13.8±1.874/12.9±2.183

4/6

5/5

6±4.662/7.3±3.164

mobile text message

8.60±0.867/8.78±0.728

8.23±1.370/8.57±0.786

3-4

Berndt 2014, Germany

RCT

68 (34/34)

12.9±2.0/13.2±2.9

21/13

20/14

5.0±3.7/5.3±4.0

mobile applications

8.84±1.71/8.96±2.23

8.12±1.10/7.99±1.26

3

Charpentier 2012, France

RCT

121 (60/61)

32.9±11.7/36.8±14.1

23/37

21/40

17.6±8.9/16.9±10.5

mobile applications

9.19±1.14/8.91±0.90

8.63±1.07/9.10±1.16

6

David 2009, USA

RCT

40 (22/18)

17.7±3.0/18.2±2.3

9/13

9/9

9.0±4.2/9.5±5.6

mobile text message

8.9±1.7/8.6±0.9

8.7±1.5/8.8±0.9

3

Franklin 2008, Scotland

RCT

60 (33/27)

14.1 (11.7-15.6)/12.7 (10.5-14.8)

15/18

17/10

4.8 (2.6-8.6)/3.2 (1.7-6.7)

mobile text message

9.8±1.8/10.2±1.6

10.1±1.7/10.3±1.7

12

Rossi 2013, Italy

RCT

127 (63/64)

38.4±10.3/34.3±10.0

29/34

31/33

16.2±10.0/15.0±8.4

mobile applications

8.4±0.79/8.5±0.8

7.9±0.79/8.1±0.8

6

Kirwan 2013, Australia

RCT

72 (36/36)

35.97±10.67/34.42±/10.26

19/17

9/27

19.69±9.64/18.19±9.77

mobile applications

9.08±1.18/8.47±0.86

7.80±0.75/8.58±1.16

9

Rossi 2010, Italy

RCT

130 (67/63)

35.4±9.5/36.1±9.4

30/37

26/37

17.1±10.3/15.8±10.7

mobile applications

8.2±0.8/8.4±0.7

7.8±0.8/7.9±1.1

6

  1. Note. I/C intervention group/Control group, RCT randomized controlled trial, IQR interquartile range, M/F male/female
  2. Values are Mean ± SD for continuous normal distribution, Median (IQR) and Median (range) for continuous skewed distribution
  3. Mobile text message: Using short message to intervene patients; Mobile applications: Use mobile phone applications to interact with patients and educate patients
  4. Table 1 describes the basic features of the literature